KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 252 filers reported holding KITE PHARMA INC in Q3 2017. The put-call ratio across all filers is 1.40 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,897,000 | -83.2% | 10,549 | -90.3% | 0.00% | -75.0% |
| Q2 2017 | $11,278,000 | +1315.1% | 108,787 | +971.3% | 0.00% | – |
| Q1 2017 | $797,000 | +294.6% | 10,155 | +125.4% | 0.00% | – |
| Q4 2016 | $202,000 | -20.2% | 4,506 | -0.5% | 0.00% | – |
| Q3 2016 | $253,000 | -96.1% | 4,530 | -95.7% | 0.00% | -100.0% |
| Q4 2015 | $6,433,000 | +22.0% | 104,395 | +10.3% | 0.00% | +50.0% |
| Q3 2015 | $5,272,000 | +105340.0% | 94,678 | +107488.6% | 0.00% | – |
| Q2 2015 | $5,000 | – | 88 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |